Our Managing Partner, Michal Sikyta, concluded two focused days at the Swiss Biotech Association Day 2026. Attending events in established industry hubs like Basel is a practical requirement for our team, as it provides a clear, firsthand look at the current direction of the European biotech sector.
A notable part of the event was the opportunity to connect with our portfolio company, FluoSphera. Meeting with Clélia Bourgoint, Gregory Segala, and their team on the ground was a valuable addition to the trip. It is always beneficial to see our founders operating directly within one of Europe’s most active and progressive biotech environments.
As with all our ecosystem activities, being physically present in Basel serves a straightforward purpose. It allows us to speak directly with specialists, validate our understanding of the market, and actively participate in the network that supports both our fund and our founders. Consistently showing up to these focused events is how we maintain a realistic read on the industries we invest in.